Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Jürgen Geisler

A Review of the Potential Role of Human Cytomegalovirus (HCMV) Infections in Breast Cancer Carcinogenesis and Abnormal Immunity

scientific article published on 22 November 2019

A novel type of deletion in the CDKN2A gene identified in a melanoma-prone family

scientific article published on December 2006

Alterations in the p53 pathway and p16INK4a expression predict overall survival in metastatic melanoma patients treated with dacarbazine

scientific article published on 27 May 2010

An optimised, highly sensitive radioimmunoassay for the simultaneous measurement of estrone, estradiol and estrone sulfate in the ultra-low range in human plasma samples

scientific article

Aromatase inhibition: translation into a successful therapeutic approach

scientific article

Aromatase inhibitors as adjuvant treatment of breast cancer

scientific article

Aromatase inhibitors--socio-economical issues

scientific article published on 01 May 2005

Aromatase inhibitors--socioeconomical issues

scientific article published on 24 May 2007

Aromatase inhibitors: assessment of biochemical efficacy measured by total body aromatase inhibition and tissue estrogen suppression

scientific article published on 14 September 2007

Breast cancer aromatase expression evaluated by the novel antibody 677: correlations to intra-tumor estrogen levels and hormone receptor status

scientific article published on 31 October 2009

Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension

scientific article (publication date: 2012)

DNA methylation subgroups in melanoma are associated with proliferative and immunological processes

scientific article published on 6 November 2015

Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors

scientific article published on 8 October 2013

Development of aromatase inhibitors and their pharmacologic profile

scientific article

Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF(V600E) and BRAF wild-type metastatic malignant melanoma

scientific article (publication date: 2013)

Does adjuvant therapy with letrozole improve survival in postmenopausal women with early-stage breast cancer?

scientific article published on 01 July 2006

Effects of anastrozole on the intratumoral gene expression in locally advanced breast cancer

scientific article

Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer

scientific article published on 27 June 2005

Endocrine effects of aromatase inhibitors and inactivators in vivo: review of data and method limitations

scientific article

Experience with exemestane in the treatment of early and advanced breast cancer

scientific article published on 01 July 2008

Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications.

scientific article

Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome

scientific article published on 11 May 2010

Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation

scientific article

Impact of aromatase inhibitors on bone health in breast cancer patients

scientific article published on 13 October 2009

Indications and limitations of third-generation aromatase inhibitors

scientific article published on 01 May 2008

Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study

scientific article published in February 2002

Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome

scientific article published on 29 March 2017

Intratumoral estrogen disposition in breast cancer

scientific article published on 9 March 2010

Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels

scientific article

Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma

scientific article published on 15 May 2013

MGMT expression levels predict disease stabilisation, progression-free and overall survival in patients with advanced melanomas treated with DTIC.

scientific article published on 10 June 2010

Molecular profiling reveals low- and high-grade forms of primary melanoma

scientific article

Multilocus analysis of SNP and metabolic data within a given pathway

scientific article

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes

scientific article published on 17 March 2022

Performance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens

scientific article

Somatic EP300-G211S mutations are associated with overall somatic mutational patterns and breast cancer specific survival in triple-negative breast cancer

scientific article published on 21 August 2018

TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer

scientific article

The NAME trial: a direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer

scientific article published on 19 June 2019

The NEOLETEXE trial: a neoadjuvant cross-over study exploring the lack of cross resistance between aromatase inhibitors

scientific article published on 12 September 2019

Total body aromatization in postmenopausal breast cancer patients is strongly correlated to plasma leptin levels

scientific article

Treatment with aromatase inhibitors stimulates the expression of epidermal growth factor receptor-1 and neuregulin 1 in ER positive/HER-2/neu non-amplified primary breast cancers

scientific article published on 22 June 2016

Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients

scientific article published in September 2005